Search Results
Pharmaceutical Jurisprudence & Regulation eJournal

93,468 Total downloads | Link to this page | Subscribe to this eJournal (requires login)

Viewing: 1 - 50 of 375 papers

1.

SARS-CoV-2 Transmission Dynamics Should Inform Policy

Number of pages: 16 Posted: 21 Sep 2020
Accepted Paper Series
University of St. Andrews - Division of Infection and Global Health, Harvard Pilgrim Health Care, Harvard University - Center for Communicable Disease Dynamics and Kent State University - College of Public Health
Downloads 12,205
2.

Drugged Out: How Cognitive Bias Hurts Drug Innovation

51 San Diego Law Review 419 (2014)
Number of pages: 90 Posted: 01 Sep 2013 Last Revised: 09 Aug 2014
Accepted Paper Series
Loyola University of Chicago School of Law
Downloads 11,242
3.

Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments

Number of pages: 15 Posted: 21 Jan 2021 Last Revised: 22 Aug 2021
Working Paper Series
Universidad EAFIT, University of Toronto and US Public Health Service
Downloads 9,284
4.

Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs

Journal of Law, Medicine and Ethics, 2013, Vol. 14, No. 3: 590-610
Number of pages: 11 Posted: 20 Jun 2013 Last Revised: 11 Apr 2020
Accepted Paper Series
Rowan University School of Osteopathic Medicine, York University and Harvard Medical School
Downloads 9,020
5.

Correlates and Disparities of COVID-19 Vaccine Hesitancy

Number of pages: 20 Posted: 12 Aug 2020
Working Paper Series
Texas A&M University, The George Washington University, Department of Communication, Baylor College of Medicine, Department of Pediatrics and Molecular Virology & Microbiology, Case Western Reserve University - Department of Economics, Wesleyan University - Government and Oklahoma State University - Stillwater
Downloads 4,540
6.

Drug Regulation in the Philippines

Number of pages: 14 Posted: 24 Apr 2009
Working Paper Series
University of the Philippines, Los Baños - National College of Public Administration and Governance
Downloads 2,004
7.

A First Literature Review: Lockdowns Only Had a Small Effect on COVID-19

Number of pages: 21 Posted: 25 Jan 2021 Last Revised: 26 Jan 2021
Working Paper Series
CEPOS
Downloads 1,727
8.

Why Neuroscience Matters for a Rational Drug Policy

Minnesota Journal of Law, Science & Technology, 2010
Number of pages: 14 Posted: 10 Apr 2009
Accepted Paper Series
Baylor College of Medicine and affiliation not provided to SSRN
Downloads 1,325
9.

College Students' COVID-19 Vaccine Hesitancy

Synnott, C. K. (2021) College Students' COVID-19 Vaccine Hesitancy. The Journal of Higher Education Management, 36(2), 152-159
Number of pages: 21 Posted: 23 Dec 2020 Last Revised: 23 Nov 2021
Accepted Paper Series
Eastern Connecticut State University
Downloads 1,272
10.

Dosing Discrimination: Regulating PDMP Risk Scores

110 California Law Review 47 (2022)
Number of pages: 69 Posted: 19 Jan 2021 Last Revised: 02 Mar 2022
Accepted Paper Series
University of California Hastings College of Law
Downloads 1,148
11.

Death Toll of Price Limits and Protectionism in the Russian Pharmaceutical Market

Number of pages: 42 Posted: 20 Apr 2021
Working Paper Series
University of Southern California and New Economic School
Downloads 1,119
12.

Sudden Onset of Myelitis after COVID-19 Vaccination: An Under-Recognized Severe Rare Adverse Event

Number of pages: 7 Posted: 17 May 2021
Working Paper Series
University of Illinois at Chicago and University of Iowa - Department of Neurology
Downloads 1,115
13.

Evidence of Protective Role of Ultraviolet-B (UVB) Radiation in Reducing COVID-19 Deaths

Scientific Reports, 10:17705, October 2020
Number of pages: 55 Posted: 01 May 2020 Last Revised: 03 Nov 2020
Accepted Paper Series
Goethe University Frankfurt, Goethe University Frankfurt and Goethe University Frankfurt
Downloads 1,095
14.

Big Data and Pharmacovigilance: Using Health Information Exchanges to Revolutionize Drug Safety

99 Iowa L. Rev. 225 (2013)
Number of pages: 68 Posted: 08 Apr 2013 Last Revised: 02 May 2015
Accepted Paper Series
University of Surrey School of Law
Downloads 987
15.

Regulation of Pharmaceuticals in Canada

CANADIAN HEALTH LAW AND POLICY, 3rd ed., J. Downie, T. Caulfield & C. Flood, ed., Toronto. Butterworths, pp. 318-387, 2007
Number of pages: 56 Posted: 15 Nov 2012 Last Revised: 06 Apr 2014
Accepted Paper Series
University of Toronto - Faculty of Law and University of Manitoba - Faculty of Law (deceased)
Downloads 972
16.

The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 Pandemic

Research Paper 116, South Centre, Geneva (August 2020), FSU College of Law, Public Law Research Paper No. 930, FSU College of Law, Law, Business & Economics Paper No. 20-16
Number of pages: 40 Posted: 28 Aug 2020
Working Paper Series
Florida State University - College of Law
Downloads 895
17.

COVID-19 Futures: A Framework for Exploring Medium and Long-Term Impacts

Number of pages: 15 Posted: 03 Sep 2020
Working Paper Series
Anthrologica, London School of Economics & Political Science (LSE) - Institute of Global Affairs, Harvard University - Center for Communicable Disease Dynamics, Wellcome Trust, Department of Ecology and Evolutionary Biology & the Princeton School of Public & International Affairs, Princeton University, The University of Sydney - Marie Bashir Institute for Infectious Diseases and Biosecurity, Department of Ecology and Evolutionary Biology & the Princeton School of Public & International Affairs, Princeton University, University of Edinburgh and Wellcome Trust
Downloads 846
18.

An Unnecessary Proposal: A WTO Waiver of Intellectual Property Rights for COVID-19 Vaccines

Cato Institute, Free Trade Bulletin No.78 (2020)
Number of pages: 5 Posted: 02 Feb 2021
Accepted Paper Series
University of Central Florida
Downloads 634
19.

Unfavorable Hydroxychloroquine COVID-19 Research Associated with Authors Having a History of Political Party Donations

Number of pages: 25 Posted: 12 Oct 2020
Working Paper Series
Larkin Community Hospital, The Medical College of Wisconsin, Eastern Michigan University, Hillsdale College - Department of Economics and Medical College of Wisconsin
Downloads 631
20.

Prescription Drug Policing: The Right to Health Information Privacy Pre- and Post-Carpenter

69 Duke Law Journal 775 (2020)
Number of pages: 79 Posted: 20 Aug 2018 Last Revised: 22 Apr 2020
Accepted Paper Series
University of California Hastings College of Law
Downloads 540
21.

A Prescription for Excessive Drug Pricing: Leveraging Government Patent Use for Health

18 Yale J. L. & Tech. 275 (2016), Yale Law School, Public Law Research Paper No. 577, Yale Law & Economics Research Paper No. 560
Number of pages: 80 Posted: 03 Sep 2016 Last Revised: 21 Sep 2016
Accepted Paper Series
Hagens Berman Sobol Shapiro, Yale University - Law School, Independent and Yale University, Law School, Students
Downloads 534
22.

Who 'Owns' the Data in a Coronavirus Tracing (And/or Tracking) App?

Coronavirus and the Law in Europe, Examining coronavirus-related legislation and its consequences in European states 2020
Number of pages: 25 Posted: 23 Aug 2020
Working Paper Series
Trento University, Faculty of Law
Downloads 511
23.

Allocation of COVID-19 Vaccines Under Limited Supply

Number of pages: 37 Posted: 31 Aug 2020 Last Revised: 28 Sep 2020
Working Paper Series
University of Illinois at Urbana-Champaign, City University of Hong Kong (CityU) - Department of Management Sciences, Massachusetts Institute of Technology (MIT) - School of Engineering and University of Illinois at Urbana-Champaign
Downloads 487
24.

Facilitating Access to Cross-Border Supplies of Patented Pharmaceuticals: The Case of the COVID-19 Pandemic

Journal of International Economic Law (Oxford), Volume 23, Issue 3, pp. 535-561, Sept. 2020, FSU College of Law, Law, Business & Economics Paper No. 20-14, Duke Law School Public Law & Legal Theory Series No. 2020-46, FSU College of Law, Public Law Research Paper No. 927
Number of pages: 27 Posted: 25 Jul 2020 Last Revised: 17 Nov 2020
Working Paper Series
Florida State University - College of Law and Duke University School of Law
Downloads 431
25.

The Potential Public Health and Economic Value of a Hypothetical COVID-19 Vaccine in the United States: Use of Cost-Effectiveness Modeling to Inform Vaccination Prioritization

Number of pages: 47 Posted: 25 Sep 2020
Working Paper Series
Quadrant Health Economics Inc, Quadrant Health Economics Inc, Quadrant Health Economics Inc and Harvard University
Downloads 417
26.

A Call to Prosecute Drug Company Fraud As Organized Crime

Number of pages: 51 Posted: 17 Jul 2019
Working Paper Series
James Madison University - Finance and Business Law Program
Downloads 407
27.

The Effect of State Marijuana Legalizations: 2021 Update

Cato Institute, Policy Analysis No. 908
Number of pages: 40 Posted: 19 Mar 2021
Accepted Paper Series
Western Carolina University, Cato Institute, Cato Institute and Cato Institute
Downloads 404
28.
Downloads 402
29.

The U.S. Biologics Price Competition and Innovation Act of 2009 Triggers Public Debates, Regulatory/Policy Risks, and International Trade Concerns

Global Trade and Customs Journal, Vol. 6, No. 11 & 12, 2011
Number of pages: 34 Posted: 03 Nov 2011
Accepted Paper Series
The Kogan Law Group, P.C.
Downloads 399
30.

Deploying Prescription Drug Monitoring to Address the Overdose Crisis: Ideology Meets Reality

Indiana Health Law Review, Vol. 15, No. 2, pp. 139 - 187 (2018), Northeastern University School of Law Research Paper No. 323-2018
Number of pages: 49 Posted: 09 May 2018 Last Revised: 29 May 2018
Accepted Paper Series
Northeastern University - School of Law; Northeastern University - Bouvé College of Health Sciences
Downloads 388
31.

Allocating Medicine Fairly in an Unfair Pandemic

2021 University of Illinois Law Review 1085 (2021), U Denver Legal Studies Research Paper No. 20-26
Number of pages: 52 Posted: 28 Sep 2020 Last Revised: 15 Jun 2021
Accepted Paper Series
University of Denver Sturm College of Law
Downloads 386
32.

Manufacturing and Regulatory Barriers to Generic Drug Competition: A Structural Model Approach

Number of pages: 45 Posted: 24 Mar 2018 Last Revised: 10 Jan 2022
Working Paper Series
University of Illinois at Urbana-Champaign - Gies College of Business, University of Michigan, Stephen M. Ross School of Business and University of Michigan, Stephen M. Ross School of Business
Downloads 376
33.

Ethical Payment to Participants in Human Infection Challenge Studies, with a Focus on SARS-CoV-2: Report and Recommendations

Number of pages: 116 Posted: 16 Aug 2020
Working Paper Series
Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Pennsylvania - Perelman School of Medicine, Independent, Bank of America, Faculty of Law & Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, University of Sheffield, National Bureau of Economic Research (NBER)Dept. of Economics, Stanford University, University of Arkansas for Medical Sciences - College of Medicine and Independent
Downloads 364
34.

The Mensing Conundrum: Litigating Generic Drug Injuries in California

California Business Practice (September 2013)
Number of pages: 12 Posted: 10 Apr 2013 Last Revised: 20 Sep 2014
Accepted Paper Series
University of San Diego- School of Business Administration, University of San Diego - School of Business Administration and University of San Diego - School of Business
Downloads 347
35.

The Price Tag of 'Pay-for-Delay'

UC Hastings Research Paper Forthcoming
Number of pages: 53 Posted: 18 May 2021 Last Revised: 27 Aug 2021
Working Paper Series
UC Hastings Law
Downloads 310
36.

Pharmaceutical Antitrust: What the Trump Administration Can Do

Concurrences: Competition Law Review 63 (No. 4, 2016)
Number of pages: 3 Posted: 05 Dec 2016
Accepted Paper Series
Rutgers Law School
Downloads 308
37.

Synergic Viral-Bacterial Co-Infection in Catalase-Deficient COVID-19 Patients Causes Suppressed Innate Immunity and Lung Damages Due to Detrimental Elevation of Hydrogen Peroxide Concentration

Number of pages: 26 Posted: 17 Jul 2020 Last Revised: 15 Sep 2020
Working Paper Series
University of Hamburg - Center for Hybrid Nanostructures and University of Hamburg - Hamburg Center for Health Economics
Downloads 307
38.

The Food and Drug Administration's Evolving Regulation of Press Releases: Limits and Challenges

Food and Drug Law Journal, Vol. 61, p. 623, 2006
Number of pages: 31 Posted: 25 Apr 2007
Accepted Paper Series
Arnold & Porter, Southern Methodist University - Dedman School of Law and Pharmaceutical Research and Manufacturers of America (PhRMA)
Downloads 299
39.

New Business Models for Sustainable Antibiotics

Centre on Global health Security Working Group Papers, Chatham House (The Royal Institute of International Affairs), Working Groups on Antimicrobial Resistance, Paper 1, February, 2014 , Boston Univ. School of Law, Public Law Research Paper No. 14-10, Boston Univ. School of Law, Law and Economics Research Paper No. 14-10
Number of pages: 34 Posted: 20 Feb 2014
Accepted Paper Series
Boston University School of Law
Downloads 295
40.

Expanding Access to Patents for COVID-19

Burris, S., de Guia, S., Gable, L., Levin, D.E., Parmet, W.E., Terry, N.P. (Eds.) (2020). Assessing Legal Responses to COVID-19. Boston: Public Health Law Watch, University of Utah College of Law Research Paper No. 390
Number of pages: 5 Posted: 03 Sep 2020 Last Revised: 03 Sep 2020
Accepted Paper Series
University of Utah - S.J. Quinney College of Law
Downloads 294
41.

Drug Prices, Patents and Access to Life-Saving Medicines: Changes Are Urgently Needed in the COVID-19 Era

Forthcoming in the European Intellectual Property Review (EIPR)
Number of pages: 11 Posted: 08 Feb 2021 Last Revised: 05 May 2021
Working Paper Series
Brunel University London - Brunel Law School
Downloads 286
42.

Exit Route? The Case for Variolation Against COVID-19

Number of pages: 29 Posted: 25 Jun 2020
Working Paper Series
Independent
Downloads 278
43.

The Role of General Risk Preferences in Messaging About COVID-19 Vaccine Take-Up

Number of pages: 23 Posted: 03 Aug 2020
Working Paper Series
Vanderbilt University, University of Chicago - Booth School of Business and Stanford University - Department of Psychology
Downloads 271
44.

The Open COVID Pledge: Design, Implementation and Preliminary Assessment of an Intellectual Property Commons

2021 Utah Law Review 833 (2021), University of Utah College of Law Research Paper No. 416
Number of pages: 92 Posted: 08 Feb 2021 Last Revised: 06 Nov 2021
Accepted Paper Series
University of Utah - S.J. Quinney College of Law
Downloads 270
45.

Evidence and Extrapolation: Mechanisms for Regulating Off-Label Uses of Drugs and Devices

Duke Law Journal, Vol. 64, No. 3, 2014, Yale Law & Economics Research Paper # 492
Number of pages: 59 Posted: 22 Feb 2014 Last Revised: 02 May 2015
Accepted Paper Series
University of Surrey School of Law and Yale University - Yale Law School
Downloads 253
46.

Addressing Exclusivity Issues During the COVID-19 Pandemic and Beyond

Forthcoming, I. Glenn Cohen, Abbe Gluck, Katherine Kraschel, & Carmel Shachar, COVID-19 and the Law: Disruption, Impact and Legacy. Cambridge University Press, 2022
Number of pages: 15 Posted: 05 Aug 2021 Last Revised: 18 Aug 2021
Accepted Paper Series
Harvard-MIT Center for Regulatory Science, University of Copenhagen - Faculty of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 243
47.

The Big Data Regulator, Rebooted: Why and How the FDA Can and Should Disclose Confidential Data on Prescription Drugs and Vaccines

109 Calif. L. Rev. 493 (2021), Yale Law School, Public Law Research Paper Forthcoming
Number of pages: 66 Posted: 29 Sep 2020 Last Revised: 16 Jun 2021
Working Paper Series
Columbia Law School and Yale University - Law School
Downloads 243
48.

Mortality after Remdesivir Treatment of Pneumonia in Hospitalised Patients with Laboratory Confirmed COVID-19: National Data in the Italian Real-World Practice Collected by the AIFA Monitoring Register.

Number of pages: 15 Posted: 18 Mar 2021
Working Paper Series
The Italian Medicines Agency (AIFA), The Italian Medicines Agency (AIFA), The Italian Medicines Agency (AIFA), The Italian Medicines Agency (AIFA) and Italian Medicines Agency
Downloads 237
49.

New Drugs to Tackle Antimicrobial Resistance: Analysis of EU Policy Options

Number of pages: 52 Posted: 25 Aug 2015
Working Paper Series
Office of Health Economics and Office of Health Economics
Downloads 237
50.

Competition and Risk

Number of pages: 77 Posted: 03 Apr 2020 Last Revised: 02 Jul 2021
Working Paper Series
Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School
Downloads 232